This inventor holds 4 USPTO granted patents and 3 published patent applications. Top assignees: Beth Israel Deaconess Medical Center, Inc., University of California. Active years: 2018-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
4 out of 541 
1 out of 16,058 
Years Active: 2018-2026
Title: The Innovations of Jeffrey E. Saffitz
Introduction
Jeffrey E. Saffitz is a notable inventor based in Waban, MA (US). He has made significant contributions to the field of cardiology through his innovative research and patents. With a total of 4 patents, Saffitz has focused on advancing methods for diagnosing and treating arrhythmogenic cardiomyopathy (ACM).
Latest Patents
Saffitz's latest patents include groundbreaking methods for diagnosing ACM by detecting cardiac intercalated disk proteins in buccal cells. These methods involve evaluating desmosomal and gap junction proteins, such as plakoglobin, plakophilin 1, desmoplakin, and Cx43. The innovative techniques not only aid in diagnosis but also encompass selecting and administering appropriate treatments for ACM.
Career Highlights
Saffitz is affiliated with Beth Israel Deaconess Medical Center, Inc., where he continues to contribute to medical research and innovation. His work has been instrumental in enhancing the understanding of cardiac conditions and improving patient outcomes.
Collaborations
One of his notable collaborators is Angeliki Asimaki, with whom he has worked on various research projects aimed at advancing cardiac health.
Conclusion
Jeffrey E. Saffitz's contributions to the field of cardiology through his patents and research are commendable. His innovative approaches to diagnosing and treating arrhythmogenic cardiomyopathy have the potential to significantly impact patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile